» Articles » PMID: 15317691

Establishment and Maintenance of Human Embryonic Stem Cell Lines on Human Feeder Cells Derived from Uterine Endometrium Under Serum-free Condition

Overview
Journal Biol Reprod
Date 2004 Aug 20
PMID 15317691
Citations 31
Authors
Affiliations
Soon will be listed here.
Abstract

Human embryonic stem (hES) cells are usually established and maintained on mouse embryonic fibroblast (MEFs) feeder layers. However, it is desirable to develop human feeder cells because animal feeder cells are associated with risks such as viral infection and/or pathogen transmission. In this study, we attempted to establish new hES cell lines using human uterine endometrial cells (hUECs) to prevent the risks associated with animal feeder cells and for their eventual application in cell-replacement therapy. Inner cell masses (ICMs) of cultured blastocysts were isolated by immunosurgery and then cultured on mitotically inactivated hUEC feeder layers. Cultured ICMs formed colonies by continuous proliferation and were allowed to proliferate continuously for 40, 50, and 55 passages. The established hES cell lines (Miz-hES-14, -15, and -9, respectively) exhibited typical hES cells characteristics, including continuous growth, expression of specific markers, normal karyotypes, and differentiation capacity. The hUEC feeders have the advantage that they can be used for many passages, whereas MEF feeder cells can only be used as feeder cells for a limited number of passages. The hUECs are available to establish and maintain hES cells, and the high expression of embryotrophic factors and extracellular matrices by hUECs may be important to the efficient growth of hES cells. Clinical applications require the establishment and expansion of hES cells under stable xeno-free culture systems.

Citing Articles

Xeno-free generation of new Yazd human embryonic stem cell lines (Yazd4-7) as a prior stage toward good manufacturing practice of clinical-grade raw materials from discarded embryos: A lab resources report.

Hajizadeh-Tafti F, Golzadeh J, Akyash F, Tahajjodi S, Farashahi-Yazd E, Heidarian-Meimandi H Int J Reprod Biomed. 2023; 21(8):619-628.

PMID: 37885973 PMC: 10598466. DOI: 10.18502/ijrm.v21i8.14017.


The Role of Genetically Modified Human Feeder Cells in Maintaining the Integrity of Primary Cultured Human Deciduous Dental Pulp Cells.

Ibano N, Inada E, Otake S, Kiyokawa Y, Sakata K, Sato M J Clin Med. 2022; 11(20).

PMID: 36294410 PMC: 9605397. DOI: 10.3390/jcm11206087.


Plant-derived human recombinant growth factors and serum albumin maintain stemness of human-induced pluripotent stem cells.

Lee Y, Lee H, Ham S, Jeong D, Lee M, Lee U Cell Biol Int. 2021; 46(1):139-147.

PMID: 34694043 PMC: 9298993. DOI: 10.1002/cbin.11715.


The Use of Stem Cell-Derived Organoids in Disease Modeling: An Update.

Azar J, Bahmad H, Daher D, Moubarak M, Hadadeh O, Monzer A Int J Mol Sci. 2021; 22(14).

PMID: 34299287 PMC: 8303386. DOI: 10.3390/ijms22147667.


Diagnosis and treatment of type 1 diabetes at the dawn of the personalized medicine era.

Akil A, Yassin E, Al-Maraghi A, Aliyev E, Al-Malki K, Fakhro K J Transl Med. 2021; 19(1):137.

PMID: 33794915 PMC: 8017850. DOI: 10.1186/s12967-021-02778-6.